Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32

Clinical trial NCT00116012 · COMPLETED

Trial details

NCT number: NCT00116012
Sponsor: ARCA Biopharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronary Disease

Start date: 2005-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.